{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:50:43Z","timestamp":1793141443983,"version":"4.5.0"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","award":["100847"],"award-info":[{"award-number":["100847"]}],"id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Cytomegalovirus (CMV) infection poses a significant risk to kidney transplant recipients. This study investigated CMV disease incidence, outcomes, and management challenges in racial and ethnic minority populations following kidney transplantation.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>This single-center, mixed-methods study included a retrospective cohort analysis of kidney transplant recipients (n = 58) and qualitative surveys of healthcare providers. Patients were categorized as minorities (n = 49) or non-Hispanic whites (n = 9). The primary outcome was CMV disease incidence. Secondary outcomes included graft failure, mortality, and identification of management barriers.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>The cumulative incidence of CMV disease was higher in minorities than in non-Hispanic whites (12.3% vs. 0%, p = 0.58), although the difference was not statistically significant. All graft failures (8.6%, n = 5) occurred in the minority group. Although not statistically significant, all-cause mortality was higher in the minority group (24.5% vs. 11.1%, p = 0.54), with 46.2% of the deaths occurring within 90 days of CMV diagnosis. Qualitative analysis revealed challenges in diagnosis, treatment-related side effects, medication costs, and insurance barriers. The providers emphasized the importance of interdisciplinary collaboration and standardized protocols.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>While limited by the small sample size, this study highlights potential disparities in the incidence and outcomes of CMV disease among minority kidney transplant recipients, suggesting that barriers in care and access may contribute to these differences. These hypothesis-generating findings underscore the need for larger multicenter studies to validate these patterns and to inform targeted strategies that may reduce inequities in post-transplant outcomes.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0317383","type":"journal-article","created":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T18:23:26Z","timestamp":1738175006000},"page":"e0317383","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["Taming the transplant troll: Exploring racial and ethnic disparities in cytomegalovirus infection among kidney transplant patients"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5402-0240","authenticated-orcid":true,"given":"M. Gabriela","family":"Cabanilla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashlee","family":"Dauenhauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Briana","family":"St John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deirdre","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Larson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,1,29]]},"reference":[{"issue":"21","key":"pone.0317383.ref001","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1056\/NEJM200011233432106","article-title":"Racial disparities in access to renal transplantation\u2013clinically appropriate or due to underuse or overuse?","volume":"343","author":"AM Epstein","year":"2000","journal-title":"N Engl J Med"},{"issue":"4","key":"pone.0317383.ref002","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1111\/ajt.12143","article-title":"Trends in the inactive kidney transplant waitlist and implications for candidate survival","volume":"13","author":"ME Grams","year":"2013","journal-title":"Am J Transplant"},{"issue":"2","key":"pone.0317383.ref003","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1053\/j.ajkd.2004.04.039","article-title":"Access to renal transplantation among American Indians and Hispanics","volume":"44","author":"TD Sequist","year":"2004","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"pone.0317383.ref004","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/ctr.12288","article-title":"The impact of early cytomegalovirus infection after kidney transplantation on long-term graft and patient survival","volume":"28","author":"YV Smedbr\u00e5ten","year":"2014","journal-title":"Clin Transplant"},{"issue":"9","key":"pone.0317383.ref005","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1097\/TP.0000000000000641","article-title":"Impact of cytomegalovirus on long-term mortality and cancer risk after organ transplantation","volume":"99","author":"R Desai","year":"2015","journal-title":"Transplantation"},{"issue":"11","key":"pone.0317383.ref006","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1086\/652438","article-title":"Cytomegalovirus seroprevalence in the United States: The national health and nutrition examination surveys, 1988\u20132004","volume":"50","author":"SL Bate","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"4","key":"pone.0317383.ref007","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/rmv.655","article-title":"Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection","volume":"20","author":"MJ Cannon","year":"2010","journal-title":"Rev Med Virol"},{"issue":"2","key":"pone.0317383.ref008","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0891-5520(05)70158-6","article-title":"Infectious complications of solid organ transplantations","volume":"15","author":"DM Simon","year":"2001","journal-title":"Infect Dis Clin North Am"},{"issue":"7","key":"pone.0317383.ref009","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1086\/591532","article-title":"Impact of current transplantation management on the development of cytomegalovirus disease after renal transplantation","volume":"47","author":"R San Juan","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"5","key":"pone.0317383.ref010","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/23808993.2021.1964951","article-title":"Individualized management of cytomegalovirus in solid organ transplant recipients","volume":"6","author":"H Saeed","year":"2021","journal-title":"Expert Rev Precis Med Drug Dev"},{"issue":"4","key":"pone.0317383.ref011","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"E Von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"pone.0317383.ref012","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1001\/archinte.1979.03630400011006","article-title":"Cytomegalovirus: the troll of transplantation","volume":"139","author":"HH Balfour","year":"1979","journal-title":"Arch Intern Med"},{"issue":"2","key":"pone.0317383.ref013","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research Electronic Data Capture (REDCap): A metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"PA Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"pone.0317383.ref014","doi-asserted-by":"crossref","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap Consortium: Building an international community of software partners","volume":"95","author":"PA Harris","year":"2019","journal-title":"J Biomed Inform"},{"key":"pone.0317383.ref015","unstructured":"US Department of Health and Human Services, Health Resources and Services Administration. MUA (medically underserved areas) Find. http:\/\/muafind.hrsa.gov\/index.aspx. Accessed October 9, 2023."},{"issue":"3","key":"pone.0317383.ref016","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/cid\/ciae321","article-title":"Consensus definitions of cytomegalovirus (CMV) infection and disease in transplant patients including resistant and refractory CMV for use in clinical trials: 2024 update from the transplant associated virus infections forum","volume":"79","author":"P Ljungman","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"4","key":"pone.0317383.ref017","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofv180","article-title":"The excess burden of cytomegalovirus in African American communities: A geospatial analysis","volume":"2","author":"PM Lantos","year":"2015","journal-title":"Open Forum Infect Dis"},{"issue":"4","key":"pone.0317383.ref018","doi-asserted-by":"crossref","first-page":"e1140","DOI":"10.1371\/journal.pntd.0001140","article-title":"Congenital cytomegalovirus mortality in the United States, 1990\u20132006","volume":"5","author":"BN Bristow","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"pone.0317383.ref019","first-page":"e13267","article-title":"Infections after kidney transplantation: A comparison of mTOR-Is and CNIs as basic immunosuppressants","volume":"22","author":"Transpl Infect Dis","year":"2020","journal-title":"A systematic review and meta-analysis"},{"issue":"3","key":"pone.0317383.ref020","first-page":"328","article-title":"Disparities in cytomegalovirus infection rates by race and ethnicity among pediatric allogeneic hematopoietic cell transplantation recipients at a single center","volume":"30","author":"CLK Boge","year":"2024","journal-title":"Transplant Cell Ther"},{"issue":"6","key":"pone.0317383.ref021","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1086\/514142","article-title":"Posttransplant lymphoproliferative disease in primary Epstein-Barr virus infection after liver transplantation: The role of cytomegalovirus disease","volume":"176","author":"R Ma\u00f1ez","year":"1997","journal-title":"J Infect Dis"},{"issue":"3","key":"pone.0317383.ref022","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/acel.12059","article-title":"Cytomegalovirus infection is associated with increased mortality in the older population","volume":"12","author":"GM Savva","year":"2013","journal-title":"Aging Cell"},{"issue":"1","key":"pone.0317383.ref023","first-page":"174","article-title":"Cytomegalovirus and kidney transplantation: An update","volume":"7","author":"MF Sener","year":"2023","journal-title":"OBM Transplantation"},{"issue":"4","key":"pone.0317383.ref024","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/ajt.12103","article-title":"Cytomegalovirus in solid organ transplantation","volume":"13","author":"RR Razonable","year":"2013","journal-title":"Am J Transplant"},{"issue":"1","key":"pone.0317383.ref025","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/TP.0b013e318238dab3","article-title":"Valganciclovir prophylaxis versus preemptive therapy in cytomegalovirus-positive renal allograft recipients: 1-year results of a randomized clinical trial","volume":"93","author":"O Witzke","year":"2012","journal-title":"Transplantation"},{"issue":"9","key":"pone.0317383.ref026","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1111\/j.1600-6143.2006.01413.x","article-title":"Prophylactic versus preemptive oral valganciclovir for the management of cytomegalovirus infection in adult renal transplant recipients","volume":"6","author":"JA Khoury","year":"2006","journal-title":"Am J Transplant"},{"issue":"1","key":"pone.0317383.ref027","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1600-6143.2007.02031.x","article-title":"Valacyclovir prophylaxis versus preemptive valganciclovir therapy to prevent cytomegalovirus disease after renal transplantation","volume":"8","author":"T Reischig","year":"2008","journal-title":"Am J Transplant"},{"issue":"8","key":"pone.0317383.ref028","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1080\/10428194.2022.2042686","article-title":"Letermovir vs. high-dose valacyclovir for cytomegalovirus prophylaxis following haploidentical or mismatched unrelated donor allogeneic hematopoietic cell transplantation receiving post-transplant cyclophosphamide","volume":"63","author":"CW Freyer","year":"2022","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"pone.0317383.ref029","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1432-2277.2010.01205.x","article-title":"Racial and ethnic disparities in kidney transplantation","volume":"24","author":"SK Malek","year":"2011","journal-title":"Transpl Int"},{"issue":"2","key":"pone.0317383.ref030","first-page":"202","article-title":"A contemporary analysis of outcomes and modifiable risk factors of ethnic disparities in kidney transplantation","volume":"111","author":"LJ Wilkins","year":"2019","journal-title":"J Natl Med Assoc"},{"issue":"2","key":"pone.0317383.ref031","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/j.1600-6143.2009.03009.x","article-title":"Access and outcomes among minority transplant patients, 1999\u20132008, with a focus on determinants of kidney graft survival","volume":"10","author":"P-Y Fan","year":"2010","journal-title":"Am J Transplant"},{"issue":"3","key":"pone.0317383.ref032","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21767\/1791-809X.1000504","article-title":"Factors contributing to kidney allograft loss and associated consequences among post kidney transplantation patients","volume":"11","author":"H Ndemera","year":"2017","journal-title":"Health Sci J"},{"issue":"2","key":"pone.0317383.ref033","doi-asserted-by":"crossref","first-page":"e1273","DOI":"10.1097\/TXD.0000000000001273","article-title":"Death with function and graft failure after kidney transplantation: Risk factors at baseline suggest new approaches to management","volume":"8","author":"MA Merzkani","year":"2022","journal-title":"Transplant Direct"},{"issue":"7","key":"pone.0317383.ref034","doi-asserted-by":"crossref","first-page":"e0269990","DOI":"10.1371\/journal.pone.0269990","article-title":"Risk factors for graft loss and death among kidney transplant recipients: A competing risk analysis","volume":"17","author":"J Pinto-Ramirez","year":"2022","journal-title":"PLoS One"},{"issue":"4","key":"pone.0317383.ref035","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1097\/TP.0000000000003919","article-title":"Cardiometabolic and kidney protection in kidney transplant recipients with diabetes: Mechanisms, clinical applications, and summary of clinical trials","volume":"106","author":"VS Sridhar","year":"2022","journal-title":"Transplantation"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0317383","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T18:23:42Z","timestamp":1738175022000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0317383"}},"subtitle":[],"editor":[{"given":"Michael","family":"Nevels","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,1,29]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0317383","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,29]]}}}